HeyJaredThis Week in Addiction Medicine from ASAM
This Week in Addiction Medicine is an audio summary of the recent top stories and research articles from the field of addiction medicine.
- Indexed episodes, last 90 days
- 12
- Latest publication
- Sep 22, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 7, 2026
Latest episodes
Lead: Abandonment of prescribed buprenorphine for opioid use disorder, 2020-2024 (opens the original)
Read excerpt
Abandonment of prescribed buprenorphine for opioid use disorder, 2020-2024 JAMA Network Open This retrospective cohort study examined characteristics associated with abandonment of newly prescribed buprenorphine, defined as a prescription that was written but not dispensed or filled, and trends in abandonment among adults from 2020 to 2024 to inform efforts to improve buprenorphine access. Researchers found the proportion of abandoned newly prescribed buprenorphine prescriptions for opioid use d
Lead: US drug overdose deaths involving stimulants without opioids continued to rise in 2024 (opens the original)
Read excerpt
US drug overdose deaths involving stimulants without opioids continued to rise in 2024 Addictive Behaviors Reports Drug overdose deaths (DOD) peaked in 2022 before a decline in rates driven by decrease in opioid-related deaths. We are now in the ‘fourth wave’ of the overdose epidemic, described by DOD involving polysubstance use. As the decline in DOD has been driven largely by decline in deaths related to fentanyl, researchers sought to assess if DOD due to stimulants alone (without opioids) wa
Lead: US drug overdose deaths that occurred in isolation, 2022–2024 (opens the original)
Read excerpt
US drug overdose deaths that occurred in isolation, 2022–2024 NEJM Evidence Data were obtained from SUDORS (State Unintentional Drug Overdose Reporting System) for 2022-2024. Of 191,577 overdose deaths, 76% occurred in isolation with no opportunity for rescue. Of the deaths in isolation, 73% were in a house or apartment and 23% elsewhere (car, sidewalk, bar). There was a person nearby (but not present) for 29% of the deaths in a house or apartment and 13% of the deaths elsewhere. The authors sug
Lead: Nicotine e-cigarettes for cigarette smoking cessation: Recommendations to US-based clinicians (opens the original)
Read excerpt
Nicotine e-cigarettes for cigarette smoking cessation: Recommendations to US-based clinicians Journal of the American Medical Association This Special Communication summarizes the evidence on the use of e-cigarettes for smoking cessation and provides recommendations for clinicians on how to engage in conversations with adult patients who currently smoke cigarettes. Specifically, advice is provided on (1) integration of e-cigarettes into patient-centered shared decision-making conversations on th
Lead: Oral semaglutide for alcohol use disorder: A randomized clinical trial (opens the original)
Read excerpt
Oral Semaglutide for Alcohol Use Disorder: A Randomized Clinical Trial The American Journal of Psychiatry Accumulating preclinical and observational evidence suggests that glucagon-like peptide-1 receptor agonists, including semaglutide, reduce alcohol consumption. This phase 2 double-blind, randomized, parallel-arm trial evaluated the effects of oral semaglutide on alcohol craving and consumption among treatment-seeking adults with alcohol use disorder (AUD). It found that semaglutide did not s
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.
See coverage about This Week in Addiction Medicine from ASAM